Profit and cash flow diverged
Reported profit rose 34.8% but operating cash flow fell 74.8% — worth investigating whether the profit is being collected.
Importance 75 / 95 · cash quality
The strongest observations the engine found, ranked. Every line is generated from the filed numbers by a fixed rule — no opinion, no estimate.
Reported profit rose 34.8% but operating cash flow fell 74.8% — worth investigating whether the profit is being collected.
Importance 75 / 95 · cash quality
Net worth compounded at 34.3% a year over 4 years (₹2,015 → ₹6,549).
Importance 64 / 95 · financial health
Revenue grew 30.5% but only 0.36× of reported profit came through as operating cash.
Importance 62 / 95 · cash quality
Operating cash flow was only 0.36× reported profit (FY2026).
Importance 55 / 95 · cash quality
Classified by the exchange under Commodities › Chemicals › Chemicals & Petrochemicals › Explosives.
Peer set used on this page: 3 chemicals & petrochemicals.
Revenue grew 25.6% a year over 4 years, from ₹3,948 cr in FY2022 to ₹9,838 cr in FY2026. Net profit grew 39.7% a year over the same period.
Over 4 years profit compounded at 39.7% a year while revenue compounded at 25.6% a year — though FY2023 saw a one-off step-change of 78% (a merger, restructuring or a recovery off a low base), so the compounding is uneven.
Rule PROFIT_CAGR_VS_REVENUE_CAGR
Revenue compounded at 25.6% a year over 4 years (₹3,948 → ₹9,838) — though FY2023 saw a one-off step-change of 75% (a merger, restructuring or a recovery off a low base), so the compounding is uneven.
Net profit grew 34.8% year on year (FY2025 → FY2026).
Revenue grew 30.5% year on year (FY2025 → FY2026).
In Q2 FY27 (Jul–Sep 2026), revenue was ₹3,519 cr (up 69.0% on the same quarter last year) and net profit ₹650 cr (up 79.7%).
Quarterly results, the trailing-twelve-months snapshot, and verified corporate actions — kept separate from each other and from the annual story above. Every figure traces to a filed number; nothing here is external news or commentary.
Q2 FY27 revenue was ₹3,519 cr, up 69.0% from ₹2,082 cr in Q2 FY26 a year earlier.
Rule QTR_REVENUE_GROWTH_YOY
Q2 FY27 net profit was ₹650 cr, up 79.7% from ₹362 cr a year earlier.
Rule QTR_PROFIT_GROWTH_YOY
Q2 FY27 EBIT was ₹933 cr, up 79.0% from ₹521 cr a year earlier.
Rule QTR_OPERATING_PERFORMANCE_CHANGE_YOY
| Quarter | Revenue | YoY | Net profit | YoY | Net margin |
|---|---|---|---|---|---|
| Q3 FY25 | 1,973 | +38.1% | 338 | +52.1% | 17.1% |
| Q4 FY25 | 2,167 | +34.5% | 346 | +42.6% | 16.0% |
| Q1 FY26 | 2,154 | +27.1% | 353 | +17.3% | 16.4% |
| Q2 FY26 | 2,082 | +21.4% | 362 | +19.1% | 17.4% |
| Q3 FY26 | 2,548 | +29.2% | 467 | +38.2% | 18.3% |
| Q4 FY26 | 3,053 | +40.9% | 556 | +60.7% | 18.2% |
| Q1 FY27 | 3,668 | +70.3% | 666 | +89.0% | 18.2% |
| Q2 FY27 | 3,519 | +69.0% | 650 | +79.7% | 18.5% |
Trailing twelve months to 30 Sept 2026 · sum of the last 4 contiguous quarters
EBITDA margin was 28.0% in FY2026, against 19.4% in FY2022. ROE was 31.3% and ROCE 37.0% in FY2026.
EBITDA margin of 28.0% is the widest in 4 years (prior range 19.1% to 26.9%).
Rule MARGIN_AT_MULTI_YEAR_HIGH
ROE of 31.3% is well above the chemicals and petrochemicals median of 23.5%.
Debt-to-equity was 0.22x in FY2026, against 0.43x in FY2022; interest coverage 18.65x. Operating cash flow was 0.36x net profit.
Reported profit rose 34.8% but operating cash flow fell 74.8% — worth investigating whether the profit is being collected.
Rule PROFIT_UP_CASH_DOWN
Net worth compounded at 34.3% a year over 4 years (₹2,015 → ₹6,549).
Revenue grew 30.5% but only 0.36× of reported profit came through as operating cash.
Operating cash flow was only 0.36× reported profit (FY2026).
Free cash flow has been positive in 4 of the last 5 years.
Within its 3-company Chemicals & Petrochemicals peer group, it ranks 1 of 3 on return on equity and 1 of 3 on EBITDA margin. Its P/E of 72.2 compares with a peer median of 60.6.
Ranked against 3 chemicals & petrochemicals (FY2026, consolidated). No peer-relative rule fired for this company.
SOLARINDS · 1st of 3 · set median 11.1%
SOLARINDS · 1st of 3 · set median 25.9%
SOLARINDS · 1st of 3 · set median 23.5%
SOLARINDS · 3rd of 3 · set median 60.6×
On the trailing twelve months. Last full year: P/E 97.3× · P/S 17.0× · ROE 31.3%. TTM and full-year profit and revenue and EBITDA differ by more than 15% — a one-off in a recent quarter is moving the trailing figure; weigh it against the full year.
The share price is up 33.8% over 1 year, up 169% over 3 years (39.1% a year) and up 572% over 5 years (46.4% a year). These are price changes excluding dividends, adjusted for splits and bonuses, to 20 Nov 2026; it is 16.9% below its 52-week high.
Over 4 years profit (39.7% a year) and the stock (39.1% a year) compounded at roughly the same rate — but FY2022 profit (₹455) was well below the through-cycle level (~₹875), so this rate is inflated by the recovery from a low base.
Rule STOCK_TRACKED_EARNINGS · recovery
Price-action indicators as of 2026-11-20. Secondary to the fundamentals above — included for timing context, not as a signal.
Observations the engine tagged watch or deteriorating — prompts for your own research, not conclusions.
The full statements, kept deliberately secondary. Every figure traces to a BSE Integrated Filing (inline XBRL); ratios are recomputed from the normalised facts.
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 3,948 | 6,923 | 6,070 | 7,540 | 9,838 |
| Total income | 3,967 | 6,954 | 6,114 | 7,611 | 9,966 |
| EBITDA | 767 | 1,320 | 1,414 | 2,031 | 2,750 |
| Profit before tax | 607 | 1,102 | 1,161 | 1,733 | 2,365 |
| Net profit | 455 | 811 | 875 | 1,288 | 1,737 |
| EPS (₹) | 48.8 | 83.7 | 92.4 | 133.7 | 185.4 |
| Net worth | 2,015 | 2,751 | 3,427 | 4,537 | 6,549 |
| Total debt | 866 | 1,169 | 1,105 | 940 | 1,468 |
| Operating cash flow | 298 | 656 | 1,406 | 2,468 | 621 |
| Free cash flow | 17 | 177 | 858 | 1,462 | −1,072 |
| Ratio | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Growth | |||||
| Revenue growth YoY | — | 75.4 | -12.3 | 24.2 | 30.5 |
| Profit growth YoY | — | 78.1 | 7.9 | 47.2 | 34.8 |
| Profitability | |||||
| EBITDA margin % | 19.4 | 19.1 | 23.3 | 26.9 | 28.0 |
| Net margin % | 11.5 | 11.7 | 14.3 | 16.9 | 17.4 |
| Return on equity % | 22.6 | 34.0 | 28.3 | 32.3 | 31.3 |
| Return on capital % | 22.8 | 35.1 | 30.1 | 37.0 | 37.0 |
| Leverage & cash | |||||
| Debt to equity | 0.43 | 0.43 | 0.32 | 0.21 | 0.22 |
| Cash flow ÷ profit | 0.65 | 0.81 | 1.61 | 1.92 | 0.36 |
| Current ratio | 1.49 | 1.53 | 1.77 | 1.95 | 2.06 |